8,457 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Purchased by World Investment Advisors

World Investment Advisors acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 8,457 shares of the exchange traded fund’s stock, valued at approximately $762,000.

A number of other hedge funds also recently made changes to their positions in the business. FMR LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC grew its position in shares of SPDR S&P Biotech ETF by 11.9% in the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after purchasing an additional 1,137 shares during the last quarter. Van ECK Associates Corp acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $1,497,000. Parallel Advisors LLC lifted its holdings in SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock worth $3,834,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. lifted its holdings in SPDR S&P Biotech ETF by 4.4% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 160,402 shares of the exchange traded fund’s stock worth $14,445,000 after purchasing an additional 6,771 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $73.66 on Monday. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. The stock’s fifty day moving average price is $88.13 and its two-hundred day moving average price is $93.12. SPDR S&P Biotech ETF has a one year low of $70.16 and a one year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were given a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.